{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:01:58Z","timestamp":1790301718551,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bernhard-Nocht-Institut f\u00fcr Tropenmedizin"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Implementation Sci"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The COVID-19 pandemic has highlighted the need for more effective immunization programs, including in limited resource settings. This paper presents outcomes and lessons learnt from a COVID-19 vaccination campaign (VC), which used a tailored adaptive strategy to optimise vaccine uptake in the Boeny region of Madagascar.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Guided by the Dynamic Sustainability Framework (DSF), the VC implementation was regularly reviewed through multi-sectoral stakeholder feedback, key informant interviews, problem-solving meetings, and weekly monitoring of outcome indicators to identify and apply key adaptations. Qualitative data on processes were collected and analysed using a rapid assessment approach. Outcome indicators, including pre- and post-VC vaccine hesitancy and trends in vaccine doses administered, were analysed using generalized linear models. Additionally, vaccination coverage, geographic reach, and target population characteristics, and sustainability indicators, such as staff trained, facilities equipped, and degree of integration of operational and educational materials were also tracked.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Key strategy adaptations included using a proactive campaign approach, community-led awareness and outreach, particularly in remote areas, and addressing cold chain, waste management, vaccine transport, and information technology (IT) equipment gaps. Over six months, 24,888 COVID-19 vaccines were administered. The adapted strategy led to an 8% increase in doses administered weekly (RR\u2009=\u20091.08, CI 95%: 1.01-1.15). However, vaccine hesitancy among the unvaccinated population remained unchanged (\u2206\u2009=\u20090.02, CI 95%: -0.04-0.08). In terms of sustainability, 340 staff were trained, and 10 primary healthcare facilities were equipped and refurbished.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Implementing collaborative, multi-sectoral vaccination strategies that integrate healthcare services with proactive outreach and community-driven campaigns are effective in increasing vaccine coverage in resource-limited settings. It demonstrates how theory-based adaptive strategies can enhance vaccination rates, even if they do not significantly impact COVID-19 vaccine hesitancy within the community. More generally, this initiative has important implications for adult vaccination programmes other than those related to COVID-19.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13012-024-01412-5","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:36:51Z","timestamp":1736433411000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Optimizing vaccine uptake in sub-Saharan Africa: a collaborative COVID-19 vaccination campaign in Madagascar using an adaptive approach"],"prefix":"10.1186","volume":"20","author":[{"given":"Viola","family":"Pavoncello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Kislaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diavolana Koecher","family":"Andrianarimanana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rivo","family":"Rakotomalala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahinamandranto","family":"Rasamoelina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Veilleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Guth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexina Olivasoa Tsiky","family":"Zafinimampera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Ratefiarisoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivette","family":"Totofotsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheick Oumar","family":"Doumbia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rivomalala","family":"Rakotonavalona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holinirina","family":"Ramananjanahary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zely Arivelo","family":"Randriamanantany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rivo Andry","family":"Rakotoarivelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewi Ismajani","family":"Puradiredja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8833-239X","authenticated-orcid":false,"given":"Daniela","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"1412_CR1","unstructured":"Achieving 70% COVID-19 Immunization Coverage by Mid-2022. Available from: https:\/\/www.who.int\/news\/item\/23-12-2021-achieving-70-covid-19-immunization-coverage-by-mid-2022. Cited 2023 Jul 31."},{"key":"1412_CR2","doi-asserted-by":"crossref","unstructured":"Herzog LM, Norheim OF, Emanuel EJ, McCoy MS. Covax must go beyond proportional allocation of Covid vaccines to ensure fair and equitable access. BMJ. 2021;372:m4853.","DOI":"10.1136\/bmj.m4853"},{"key":"1412_CR3","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(21)00306-8","volume":"397","author":"OJ Wouters","year":"2021","unstructured":"Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. The Lancet. 2021;397:1023\u201334.","journal-title":"The Lancet"},{"key":"1412_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41591-020-1124-9","volume":"27","author":"JV Lazarus","year":"2021","unstructured":"Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27:225\u20138.","journal-title":"Nat Med"},{"key":"1412_CR5","doi-asserted-by":"publisher","first-page":"13771","DOI":"10.1016\/j.ijhydene.2022.02.112","volume":"47","author":"O Faye","year":"2022","unstructured":"Faye O, Szpunar J, Eduok U. A critical review on the current technologies for the generation, storage, and transportation of hydrogen. Int J Hydrogen Energy. 2022;47:13771\u2013802.","journal-title":"Int J Hydrogen Energy"},{"key":"1412_CR6","unstructured":"Madagascar: WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data. Available from: https:\/\/covid19.who.int. Cited 2023 Jul 31."},{"key":"1412_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.654299","volume":"9","author":"RJL Rakotonanahary","year":"2021","unstructured":"Rakotonanahary RJL, Andriambolamanana H, Razafinjato B, Raza-Fanomezanjanahary EM, Ramanandraitsiory V, Ralaivavikoa F, et al. Integrating Health Systems and Science to Respond to COVID-19 in a Model District of Rural Madagascar. Front Public Health. 2021;9: 654299.","journal-title":"Front Public Health"},{"key":"1412_CR8","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1186\/s12889-022-13150-8","volume":"22","author":"F Rasambainarivo","year":"2022","unstructured":"Rasambainarivo F, Ramiadantsoa T, Raherinandrasana A, Randrianarisoa S, Rice BL, Evans MV, et al. Prioritizing COVID-19 vaccination efforts and dose allocation within Madagascar. BMC Public Health. 2022;22:724.","journal-title":"BMC Public Health"},{"key":"1412_CR9","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ejor.2021.10.040","volume":"301","author":"K De Boeck","year":"2022","unstructured":"De Boeck K, Decouttere C, J\u00f3nasson JO, Vandaele N. Vaccine supply chains in resource-limited settings: Mitigating the impact of rainy season disruptions. Eur J Oper Res. 2022;301:300\u201317.","journal-title":"Eur J Oper Res"},{"key":"1412_CR10","unstructured":"Centers for Disease Control and Prevention (CDC). COVID-19 Vaccination Field Guide: 12 Strategies for Your Community. 2021. Available at: https:\/\/stacks.cdc.gov\/view\/cdc\/152995."},{"key":"1412_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12992-021-00745-w","volume":"17","author":"C Decouttere","year":"2021","unstructured":"Decouttere C, De Boeck K, Vandaele N. Advancing sustainable development goals through immunization: a literature review. Global Health. 2021;17:95.","journal-title":"Global Health"},{"key":"1412_CR12","unstructured":"Amt A. COVID-19: Germany\u2019s commitment to fair distribution of vaccines. German Federal Foreign Office. Available from: https:\/\/www.auswaertiges-amt.de\/en\/aussenpolitik\/themen\/covax\/2396914. Cited 2023 Jul 25."},{"key":"1412_CR13","unstructured":"Bernhard Nocht Institute for Tropical Medicine. Research projects. https:\/\/www.bnitm.de\/en\/research\/research-groups\/population\/infectious-disease-epidemiology-department\/lab-group-fusco\/research-projects. Accessed May 29, 2024. Available from: https:\/\/www.bnitm.de\/en\/research\/research-groups\/population\/infectious-disease-epidemiology-department\/lab-group-fusco\/research-projects. Cited 2024 May 29."},{"key":"1412_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1748-5908-8-117","volume":"8","author":"DA Chambers","year":"2013","unstructured":"Chambers DA, Glasgow RE, Stange KC. The dynamic sustainability framework: addressing the paradox of sustainment amid ongoing change. Implement Sci. 2013;8:117.","journal-title":"Implement Sci"},{"key":"1412_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1146\/annurev-publhealth-040617-014731","volume":"39","author":"RC Shelton","year":"2018","unstructured":"Shelton RC, Cooper BR, Stirman SW. The Sustainability of Evidence-Based Interventions and Practices in Public Health and Health Care. Annu Rev Public Health. 2018;39:55\u201376.","journal-title":"Annu Rev Public Health"},{"key":"1412_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s43058-022-00383-2","volume":"4","author":"N Moise","year":"2023","unstructured":"Moise N, Paniagua-Avila A, Barbecho JM, Blanco L, Dauber-Decker K, Simantiris S, et al. A theory-informed, rapid cycle approach to identifying and adapting strategies to promote sustainability: optimizing depression treatment in primary care clinics seeking to sustain collaborative care (The Transform DepCare Study). Implement Sci Commun. 2023;4:10.","journal-title":"Implement Sci Commun"},{"key":"1412_CR17","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1177\/1049732320921835","volume":"30","author":"C Vindrola-Padros","year":"2020","unstructured":"Vindrola-Padros C, Johnson GA. Rapid Techniques in Qualitative Research: A Critical Review of the Literature. Qual Health Res. 2020;30:1596\u2013604.","journal-title":"Qual Health Res"},{"key":"1412_CR18","unstructured":"KoboToolbox. KoboToolbox. Available from: https:\/\/www.kobotoolbox.org\/. Cited 2023 Jul 24."},{"key":"1412_CR19","unstructured":"About DHIS2. DHIS2. Available from: https:\/\/dhis2.org\/about\/. Cited 2023 Sep 4."},{"key":"1412_CR20","doi-asserted-by":"publisher","first-page":"S242","DOI":"10.1097\/MLR.0000000000001553","volume":"59","author":"AA Lewinski","year":"2021","unstructured":"Lewinski AA, Crowley MJ, Miller C, Bosworth HB, Jackson GL, Steinhauser K, et al. Applied Rapid Qualitative Analysis to Develop a Contextually Appropriate Intervention and Increase the Likelihood of Uptake. Med Care. 2021;59:S242\u201351.","journal-title":"Med Care"},{"key":"1412_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13012-021-01111-5","volume":"16","author":"AL Nevedal","year":"2021","unstructured":"Nevedal AL, Reardon CM, Opra Widerquist MA, Jackson GL, Cutrona SL, White BS, et al. Rapid versus traditional qualitative analysis using the Consolidated Framework for Implementation Research (CFIR). Implementation Sci. 2021;16:67.","journal-title":"Implementation Sci"},{"key":"1412_CR22","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2024. Available from: https:\/\/www.R-project.org."},{"key":"1412_CR23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/aje\/kwaa044","volume":"189","author":"AI Naimi","year":"2020","unstructured":"Naimi AI, Whitcomb BW. Estimating Risk Ratios and Risk Differences Using Regression. Am J Epidemiol. 2020;189:508\u201310.","journal-title":"Am J Epidemiol"},{"key":"1412_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2288-3-21","volume":"3","author":"AJ Barros","year":"2003","unstructured":"Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3:21.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"1412_CR25","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/ije\/dyw098","volume":"46","author":"J Lopez Bernal","year":"2017","unstructured":"Lopez Bernal J, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348\u201355. https:\/\/doi.org\/10.1093\/ije\/dyw098.","journal-title":"Int J Epidemiol"},{"key":"1412_CR26","doi-asserted-by":"publisher","unstructured":"Branch-Elliman W, Elwy AR, Chambers DA. Embracing dynamic public health policy impacts in infectious diseases responses: leveraging implementation science to improve practice. Front Public Health. 2023;11. Available from: https:\/\/www.frontiersin.org\/journals\/public-health\/articles\/https:\/\/doi.org\/10.3389\/fpubh.2023.1207679\/full. Cited 2024 May 29.","DOI":"10.3389\/fpubh.2023.1207679\/full"},{"key":"1412_CR27","doi-asserted-by":"publisher","unstructured":"Whitworth HS, Mounier-Jack S, Choi EM, Gallagher KE, Howard N, Kelly H, et al. Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: an updated systematic review of evidence from clinical trials. Vaccine: X. 2024;19:100486. https:\/\/doi.org\/10.1016\/j.jvacx.2024.100486.","DOI":"10.1016\/j.jvacx.2024.100486"},{"key":"1412_CR28","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1186\/s12889-023-15842-1","volume":"23","author":"J-M Kutz","year":"2023","unstructured":"Kutz J-M, Rausche P, Gheit T, Puradiredja DI, Fusco D. Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review. BMC Public Health. 2023;23:974.","journal-title":"BMC Public Health"},{"key":"1412_CR29","unstructured":"World Health Organization. Regional Office for South-East Asia. Accelerating the elimination of cervical cancer as a public health problem: Towards achieving 90\u201370\u201390 targets by 2030. World Health Organization. Regional Office for South-East Asia. 2022. https:\/\/iris.who.int\/handle\/10665\/361138."},{"key":"1412_CR30","first-page":"99","volume":"14","author":"F Kermani","year":"2023","unstructured":"Kermani F, Reandi STA. Exploring the Funding Challenges Faced by Small NGOs: Perspectives from an Organization with Practical Experience of Working in Rural Malawi. Res Rep Trop Med. 2023;14:99\u2013110.","journal-title":"Res Rep Trop Med"},{"key":"1412_CR31","unstructured":"Doctors Without Borders. Vaccination. Accessed May 29, 2024. https:\/\/www.doctorswithoutborders.org\/what-we-do\/medical-issues\/vaccination. Doctors Without Borders - USA. Available from: https:\/\/www.doctorswithoutborders.org\/what-we-do\/medical-issues\/vaccination. Cited 2024 May 29."},{"key":"1412_CR32","unstructured":"De Vito E, Parente P, de Waure C, Poscia A, Ricciardi W. A review of evidence on equitable delivery, access and utilization of immunization services for migrants and refugees in the WHO European Region. Health Evidence Network Synthesis Report, No. 53. Copenhagen: WHO Regional Office for Europe; 2017."},{"key":"1412_CR33","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3390\/vaccines10071038","volume":"10","author":"W Ekezie","year":"2022","unstructured":"Ekezie W, Awwad S, Krauchenberg A, Karara N, Dembi\u0144ski \u0141, Grossman Z, et al. Access to Vaccination among Disadvantaged, Isolated and Difficult-to-Reach Communities in the WHO European Region: A Systematic Review. Vaccines. 2022;10:1038.","journal-title":"Vaccines"}],"container-title":["Implementation Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13012-024-01412-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13012-024-01412-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13012-024-01412-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:49:24Z","timestamp":1736434164000},"score":1,"resource":{"primary":{"URL":"https:\/\/implementationscience.biomedcentral.com\/articles\/10.1186\/s13012-024-01412-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1412"],"URL":"https:\/\/doi.org\/10.1186\/s13012-024-01412-5","relation":{},"ISSN":["1748-5908"],"issn-type":[{"value":"1748-5908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Committee of Hamburg (protocol number: 2021\u201310550-BO-ff) and Madagascar (CERBM: IORGO000851 N\u00b081 MSANP\/SG\/AMM\/CERBM). The purpose of the study was explained to people who received the COVID-19 vaccine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}